|
Mom always told you that you were a unique and special person, right? But, can being unique put you at risk for not getting the medical care that’s best for you? On November 30, health care stakeholders came together to break down the "myth" of the average patient and explored how health policy decisions can impact patient care. View a summary, presentations, photos, and videos from the conference.
Keynote speakers:
Dr. Joe Selby,
Executive Director
Patient-Centered Outcomes
Research Institute |
Dr. Patrick Conway,
Chief Medical Officer
Centers for Medicare &
Medicaid Services |
Other speakers include:
- Sharon Denise Allison-Ottey, MD, Executive Director and Director of Health and Community Initiatives, The COSHAR Foundation
- Robert W. Dubois, MD, PhD, Chief Science Officer, National Pharmaceutical Council
- David M. Kent, MD, MSc, Associate Professor of Medicine, Neurology, Clinical and Translational Science; Director of the Clinical
and Translational Science (CTS) MS/PhD Program; and General Internist, Tufts Medical Center
- Dan Leonard, MA, President, National Pharmaceutical Council
- Daniel C. Malone, RPh, PhD, Professor, College of Pharmacy; Associate Professor, Mel and Enid Zuckerman College of Public Health, University of Arizona
- Paul Martino, Senior Vice President of Clinical Strategy and Innovation, WellPoint, Inc.
- David Meltzer, MD, PhD, Director, Center for Health and the Social Sciences, University of Chicago
- C. Daniel Mullins, PhD, Professor, Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy
- Lewis G. Sandy, MD, Senior VP, Clinical Advancement, UnitedHealth Group
- Ellen V. Sigal, PhD, Chairperson & Founder, Friends of Cancer Research
- Myrl Weinberg, FASAE, CAE, President, National Health Council
Through presentations by policy and health care experts, you will:
-
Understand how biology, genetics, demographics and/or individual preferences may lead to clinically important differences among patients.
-
Explore the extent to which these variations exist and should be considered in developing treatment decisions, practice guidelines, and/or coverage and reimbursement policies.
-
Understand the benefits and limitations of subgroup analyses to predict which treatments are best for individual patients.
-
Assess how failure to individualize care may contribute to poor clinical outcomes and health disparities.
-
Consider how to engage, educate and train your constituents in support of individualized patient care.
|
November 30, 2012
Omni Shoreham
Washington DC
8:00 am - 3:30 pm
SUMMARY, SLIDES, PHOTOS & VIDEOS
Connect with us:
Talk about the conference on Twitter - use #myth2012.
Need more background?
Sponsors:
|